Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Forecasted Federal grant Posted
- Opportunity number
- FOR-FD-25-013
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Applications expected due
- Not on record
- Award size
- $250,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Consumer Protection
- Agriculture
- Food and Nutrition
- Eligible applicants
-
- Public or Indian Housing Auth.
- Tribal Organizations (Not Federally Recognized)
- City/Township Governments
- State Governments
- Unrestricted
- Higher Education Inst. (Public)
- Special District Governments
- 501(c)(3) Nonprofits
- Small Businesses
- Tribal Governments (Federally Recognized)
- County Governments
- Higher Education Inst. (Private)
- Independent School Districts
- For Profit Organizations
- Non-501(c)(3) Nonprofits
- Points of contact
-
- Terrin Brown terrin.brown@fda.hhs.gov (240) 402-7610
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Food and Drug Administration is soliciting applications for a cooperative agreement to expand education, outreach, and public awareness activities on skin lightening products, with this forecast posted August 14, 2024.
Eligible applicants include public or private higher education institutions, state and local governments, tribal governments (federally recognized and non-federally recognized tribal organizations), special districts, independent school districts, public and Indian housing authorities, 501(c)(3) and non-501(c)(3) nonprofits, small businesses, and for-profit organizations. Clinical trials are not permitted.
The funding opportunity seeks innovative, community-based strategies and activities that advance science and public health awareness on the use of and potential risks from skin lightening products such as hydroquinone. Applicants will work with FDA's Office of Minority Health and Health Equity and partner stakeholders to strengthen the evidence base for education and outreach.
The program operates under CFDA 93.103 (Food and Drug Administration Research). Recent FDA cooperative agreements under this CFDA have ranged from $50 thousand to $6.8 million, with a median cooperative agreement value near $1.3 million based on recent PRISM funding. The program portfolio is predominantly cooperative agreements (58% of awards) and project grants (40%), with non-federal cost-share contributing an additional investment across the broader portfolio.
No specific award ceiling, floor, or expected number of awards is stated in this forecast. No cost-share requirement is specified. Period of performance and detailed evaluation criteria are not provided in the forecast announcement.
Forecast synopsis
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin lightening products (e.g., hydroquinone).
Applicants will propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from skin lightening products.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity